ROXSTER SYSPRO LTD

Company number 14457832 ·

Dissolved

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

ROXSTER SYSPRO LTD - Analysis Report

Company Number: 14457832

Analysis Date: 2025-07-29 12:10 UTC

Financial Health Assessment for ROXSTER SYSPRO LTD


1. Financial Health Score: D

Explanation:
The company exhibits critical signs of financial distress with negative net current assets and net liabilities, indicating that current liabilities exceed current assets. Being a micro-entity with no reported assets or income and an operating loss position suggests a fragile financial condition. The "D" grade reflects significant concerns that require urgent attention.


2. Key Vital Signs

Metric Value Interpretation
Fixed Assets £0 No long-term assets; company is asset-light or just starting.
Current Assets £0 No cash, receivables, or stock; very limited liquidity.
Current Liabilities £71 Small amount of short-term debts owed.
Net Current Assets -£71 Negative working capital; liabilities exceed short-term assets.
Total Net Assets (Equity) -£71 Shareholders’ funds are negative, indicating net liabilities.
Employees 0 No staff employed, possibly no active operational business.
Account Category Micro Smallest reporting segment, limited disclosure and scale.
Company Status Active Not in liquidation or administration, but financially weak.

3. Diagnosis

ROXSTER SYSPRO LTD is in the early stages of its lifecycle, having been incorporated in late 2022 and filing its first micro-entity accounts for the year ended 31 December 2023. The balance sheet reveals a "symptom of distress" — negative net current assets and net liabilities of £71, albeit small in absolute terms. This suggests the company has incurred some expenses perhaps related to setup or administrative costs without generating any assets or revenues yet.

The absence of fixed assets and current assets, coupled with no employees, indicates the company is either dormant in operations or has not yet commenced trading activities. The financial structure is essentially "underweight" with minimal capital invested (£0 called-up share capital noted) and a small creditor balance.

Despite these vulnerabilities, the company remains active and is compliant with filing deadlines, which is a positive sign of corporate governance. The controlling director and sole significant controller holds full ownership and voting rights, giving clear decision-making authority.

In medical terms, the company’s "vital signs" show weakness but not critical failure — akin to a patient with low energy reserves and mild dehydration but not yet in organ failure. The negative equity, while a red flag, is currently manageable given the small scale.


4. Recommendations

  • Capital Injection:
    Inject additional equity or secured loans to correct negative net assets and improve liquidity, creating a financial cushion.

  • Start Revenue-Generating Activities:
    Accelerate business operations to generate cash inflows; the absence of current assets suggests no trading yet.

  • Cost Control:
    Monitor and minimize overheads and short-term liabilities to prevent further erosion of working capital.

  • Financial Monitoring:
    Implement basic cash flow forecasting and budgeting to anticipate funding needs and prevent cash shortfalls.

  • Seek Professional Advice:
    Engage with a financial advisor or business mentor to develop a growth plan and address early-stage financial risks.

  • Maintain Compliance:
    Continue timely filing of accounts and confirmation statements to avoid penalties and maintain good standing.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.